PSMB8

protein-coding

proteasome 20S subunit beta 8, the group of Proteasome

Gene summary

The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. [provided by RefSeq, Jul 2008]

Previous symbols:
  • LMP7

MANE transcript

NM_148919.4

Inheritance

AR, AD, Digenic

ClinVar variants

P:22U:117B:75

Top phenotype

Proteasome-associated autoinflammatory syndrome 1

gnomAD constraint

pLI —, LoF o/e 0.37

Max pathogenic AF

—

Genomic locus

chr6:32,840,717-32,844,679

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~4.0 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

proteasome-associated autoinflammatory syndrome 1MODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0054698

Submitter: Ambry Genetics

proteosome-associated autoinflammatory syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0009726

Submitter: Orphanet

proteasome-associated autoinflammatory syndrome 1MODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0054698

Submitter: Ambry Genetics

proteosome-associated autoinflammatory syndromeSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0009726

Submitter: PanelApp Australia

proteasome-associated autoinflammatory syndrome 1STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0054698

Submitter: PanelApp Australia

proteasome-associated autoinflammatory syndrome 1STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0054698

Submitter: Labcorp Genetics (formerly Invitae)

proteasome-associated autoinflammatory syndrome 1DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0054698

Submitter: G2P

Clinical Genomic Database (CGD)

Proteasome-associated autoinflammatory syndrome 1AR/Digenic

Manifestation: Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic

Intervention: Allergy/Immunology/Infectious; Cardiovascular

Rationale: Individuals may have recurrent infections, and awareness may allow preventative measures as well as prompt and agressive treatment of infections; Individuals have been described with multiple manifestations, including lethal arrhythmias, and surveillance may allow early detection and management of cardiac sequelae

Comments: Digenic inheritance has been reported

Refs: 6499339; 4026345; 3618123; 8495043; 21129723; 20534754; 20159315; 21852578; 21881205; 21953331; 22441638; 26524591Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to PSMB8 variants in ClinVar

10 Conditions Cataloged
Proteosome-associated autoinflammatory syndromeTotal: 172
Proteasome-associated autoinflammatory syndrome 1Total: 50
Inborn genetic diseasesTotal: 35
not providedTotal: 27
Autoinflammatory syndromeTotal: 26
not specifiedTotal: 20
PSMB8-related disorderTotal: 8
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1, DIGENICTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_148919.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
62
clinvar
65
missense
3
clinvar
2
clinvar
109
clinvar
13
clinvar
127
nonsense
4
clinvar
3
clinvar
3
clinvar
10
start loss
0
frameshift
7
clinvar
1
clinvar
1
clinvar
9
splice donor/acceptor (+/-2bp)
2
clinvar
1
clinvar
3
Total148117750214

Highest pathogenic variant AF is 0.000024798666

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 9 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_148919.4RefSeqNP_683720.26MANE Select
ENST00000374882.8EnsemblENSP00000364016.46MANE Select
NM_004159.5RefSeqNP_004150.16Standard
ENST00000374881.3EnsemblENSP00000364015.26Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Proteasome - Homo sapiens (human)
  • Proteasome Degradation
  • The human immune response to tuberculosis
  • TLR NFkB
  • antigen processing and presentation

Biological Process

  • proteasomal protein catabolic process
  • proteasomal ubiquitin-independent protein catabolic process
  • viral process
  • protein deubiquitination
  • antigen processing and presentation

Molecular Function

  • endopeptidase activity
  • threonine-type endopeptidase activity
  • protein binding

Cellular Component

  • proteasome complex
  • nucleus
  • nucleoplasm
  • cytoplasm
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000374882
Coding exons
6
Length
3987
Individuals with no LoFs
125719
Homozygous LoFs
0
Heterozygous LoFs
29
Defined
125748
p
0.000115
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.6511381610.8560.000009771772
Missense (PolyPhen)4958.8020.83331654
Synonymous-0.9727161.31.160.00000341560
Loss of Function2.14513.50.3716.78e-7154

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0000670.000062rare
Latino/Admixed American0.0000870.000087rare
Ashkenazi Jewish0.00110.0011notable
East Asian0.000110.00011rare
Finnish00.0absent
European (Non-Finnish)0.0000910.000088rare
South Asian0.0000660.000065rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. The proteasome has an ATP-dependent proteolytic activity. This subunit is involved in antigen processing to generate class I binding peptides. Replacement of PSMB5 by PSMB8 increases the capacity of the immunoproteasome to cleave model peptides after hydrophobic and basic residues. Acts as a major component of interferon gamma-induced sensitivity. Plays a key role in apoptosis via the degradation of the apoptotic inhibitor MCL1. May be involved in the inflammatory response pathway. In cancer cells, substitution of isoform 1 (E2) by isoform 2 (E1) results in immunoproteasome deficiency. Required for the differentiation of preadipocytes into adipocytes. {ECO:0000269|PubMed:16423992, ECO:0000269|PubMed:19443843, ECO:0000269|PubMed:21881205, ECO:0000269|PubMed:8163024}.;
Disease
DISEASE: Proteasome-associated autoinflammatory syndrome 1 (PRAAS1) [MIM:256040]: An autosomal recessive autoinflammatory disorder characterized by early childhood onset of recurrent fever, joint stiffness and severe contractures of the hands and feet, and erythematous skin lesions with subsequent development of lipodystrophy and laboratory evidence of immune dysregulation. Accompanying features may include muscle weakness and atrophy, hepatosplenomegaly, and microcytic anemia. {ECO:0000269|PubMed:21129723, ECO:0000269|PubMed:21852578, ECO:0000269|PubMed:21881205, ECO:0000269|PubMed:21953331, ECO:0000269|PubMed:26524591, ECO:0000269|PubMed:26567544}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Intolerance Scores

LoFtool
0.856
RVIS EVS
0.04
RVIS percentile EVS
57.15

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.973

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.